Archive for 2016

Here’s Why Retrophin’s DUET Data Pushes Upside To 129%

Courtesy of Benzinga.

Here's Why Retrophin's DUET Data Pushes Upside To 129%

Shares of Retrophin Inc (NASDAQ: RTRX) climbed more than 4 percent after it gave positive updated DUET data at the ASN meeting. Following this development, BMO analyst Do Kim raised the price target of the Outperform-rated Retrophin shares to $46 from $40.

The revised target price implies potential upside of 129 percent over Friday’s close of $20.08.

The DUET study analyzes sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS), a rare kidney disorder.

“Our probability of success for Sparsentan increases to 55% from 45%, as we believe the results strengthen Retrophin’s case for accelerated filing and launch in 2017,” Kim wrote in a note.

The analyst believes the FDA will consider a dose titration for approval given an apparent dose-response in efficacy and tolerability (hypotension), with manageable edema rates.

Sparsentan saw 12 percent edema rate versus 3 percent for irbesartan and it’s a considerable improvement over ERAS, and in line with previous hypertension studies. Furthermore, data showed no meaningful worsening of edema from baseline.

“FDA acceptance of the proteinuria endpoint remains a risk, but we see growing evidence for proteinuria as a surrogate to kidney survival,” Kim added.

At last check, shares of Retrophin were up 4.6 percent to $21.

Latest Ratings for RTRX

Date Firm Action From To
Apr 2016 BMO Capital Initiates Coverage on Outperform
Nov 2015 JMP Securities Initiates Coverage on Market Outperform
Jun 2015 Deutsche Bank Maintains Buy

View More Analyst Ratings for RTRX


View the Latest Analyst Ratings

Posted-In: Analyst Color Long Ideas Health Care Price Target Reiteration Analyst Ratings Trading Ideas General Best of Benzinga





BioTime CEO Shares Updates On Spinal Cord Injury And Dry AMD Therapies

Courtesy of Benzinga.

BioTime CEO Shares Updates On Spinal Cord Injury And Dry AMD Therapies

BioTime, Inc. (NYSE: BTX) is a clinical-stage biotechnology company focused on regenerative medicine and pluripotent stem cell technologies. It was established by Dr. Michael D. West, the original founder of Geron Corporation (NASDAQ: GERN), who is often called “the father of regenerative medicine.”

Benzinga recently had the chance to chat with the company’s co-CEO, co-president and board director Adi Mohanty who, in a previous Benzinga article, explained what stem cells are, how they work and how BioTime uses them.

Recent Developments

During the conversation, Mohanty shared a look at some exciting, recent, company-related developments.

A couple of months ago, one of BioTime’s affiliates, Asterias Biotherapeutics Inc (NYSE: AST), of which they own roughly 50 percent, presented some data on spinal cord injury, he said. It’s early data. However, it is great to see six different patients, from four different centers, all showing improvements for the first time ever, he added.

“This shows that, maybe, pluripotent cells are having some beneficial effect. And, that’s great because we have another product [OpRegen] that we are working on, that is for dry AMD [...] that is based on the same pluripotent cell technology, and so that is also starting to show some data.”

BioTime recently finished the first (safety) cohort for OpRegen. With 12 months of patient data, they can say that “the cells are engrafted, they are in the back of the eye [and] it looks like they are doing exactly what they did” in their successful pre-clinical studies.

Furthermore, the second (effectiveness) cohort has also started and is expected to end within the next couple of months, with data out in the first months of 2017. Also for the beginning of next year, the company is expecting to open some U.S. sites, “wrapping up and speeding up the approval of that trial,”…
continue reading





7 Stocks That Rallied Three Days On Increasing Volume

Courtesy of Benzinga.




The following stocks posted three-day rallies on increasing volume spanning the trading days from November 16 to November 18:

  • Magnachip Semiconductor Corp (NYSE: MX) – Magnachip Semiconductor shares have climbed 13.85 percent over the past 52 weeks, while the S&P 500 index has gained 4.57 percent in the same period.
  • Aspen Technology, Inc. (NASDAQ: AZPN) – Aspen Technology shares have climbed 21.89 percent over the past 52 weeks, while the S&P 500 index has gained 4.57 percent in the same period.
  • Magal Security Systems Ltd. (USA) (NASDAQ: MAGS) – Magal Security shares have jumped 18.99 percent over the past 52 weeks, while the S&P 500 index has gained 4.57 percent in the same period.
  • Triton International Limited (NYSE: TRTN) – Triton International shares dropped 1.46 percent to trade at $18.56 today.
  • Novocure Ltd (NASDAQ: NVCR) – Novocure shares have dropped 38.20 percent over the past 52 weeks, while the S&P 500 index has gained 4.57 percent in the same period.
  • OraSure Technologies, Inc. (NASDAQ: OSUR) – OraSure Technologies shares have climbed 38.20 percent over the past 52 weeks, while the S&P 500 index has gained 4.57 percent in the same period.
  • VOXX International Corp (NASDAQ: VOXX) – VOXX shares have gained 4.82 percent over the past 52 weeks, while the S&P 500 index has increased 4.57 percent in the same period.

If content like this is useful to your trading/investing strategy, please email feedback@benzinga.com with the headline to let us know!*

Posted-In: Increasing VolumeMarkets Movers Trading Ideas





Why The Only Winner From Abercrombie’s Dismal Q3 Could Be American Eagle Outfitter

Courtesy of Benzinga.

Why The Only Winner From Abercrombie's Dismal Q3 Could Be American Eagle Outfitter

Before the market open last Friday Abercrombie & Fitch Co. (NYSE: ANF) reported Q3 results that missed both top- and bottom-line estimates (EPS $0.02 vs. est. $0.21; rev. $821.73 million vs. est. $830.6.0) The market responded and share price dropped by around 12 percent in trading over the day.

Analyst’s Take

After the disappointing report, BMO Capital Markets analyst John Morris reiterated a Market Perform rating for the clothing retailer and lowered his price target from $18 to $15.

The analyst highlighted further decelerated comps, which were down 14 percent in Q3 (with Hollister improving slightly,) a less-than-positive analysis of the company’s marketing campaign and an inability to “gain traction with the older millennial consumer that shunned the retailer years ago.”

Implications For The Competition

American Eagle Outfitters (NYSE: AEO) is expected to report Q3 results before the market open on November 30. The apparel competitor is expected to report EPS of $0.41 and revenue of $940.94 million.

The improving comp trends Abercrombie & Fitch saw with Hollister “could serve as a positive read through” for American Eagle, according to the analyst. Additionally, Morris noted that American Eagle should benefit from an on-trend category assortment

At the time of writing, shares of Abercrombie & Fitch were trading up 1.64 percent at $14.86; shares of American Eagle were trading slightly up at $18.15. 

Latest Ratings for AEO

Date Firm Action From To
Nov 2016 FBR Capital Downgrades Outperform Market Perform
Nov 2016 Wolfe Research Downgrades Outperform Peer Perform
Nov 2016 BlueFin Downgrades Market Outperform Market Perform

View More Analyst Ratings for AEO


View the Latest Analyst Ratings

Posted-In: BMO Capital Markets hollister John MorrisAnalyst Color Earnings News Analyst Ratings Movers Best of Benzinga





Earnings Scheduled For November 21, 2016

Courtesy of Benzinga.

Earnings Scheduled For November 21, 2016

Companies Reporting Before The Bell

  • Canadian Solar Inc. (NASDAQ: CSIQ) is estimated to report its quarterly earnings at $0.24 per share on revenue of $685.28 million.
  • Tyson Foods, Inc. (NYSE: TSN) is projected to report its quarterly earnings at $1.15 per share on revenue of $9.40 billion.
  • YY Inc (ADR) (NASDAQ: YY) is estimated to report its quarterly earnings at $0.78 per share on revenue of $305.63 million.
  • Cubic Corporation (NYSE: CUB) is expected to report its quarterly earnings at $0.17 per share on revenue of $390.30 million.
  • International Game Technology (NYSE: IGT) is projected to report its quarterly earnings at $0.44 per share on revenue of $1.24 billion.
  • Cheetah Mobile Inc (ADR) (NYSE: CMCM) is expected to report its quarterly earnings at $0.02 per share on revenue of $167.15 million.
  • Evogene Ltd (NYSE: EVGN) is estimated to report a quarterly loss at $0.07 per share on revenue of $3.40 million.

Companies Reporting After The Bell

  • Jack in the Box Inc. (NASDAQ: JACK) is projected to post its quarterly earnings at $0.88 per share on revenue of $398.67 million.
  • Beacon Roofing Supply, Inc. (NASDAQ: BECN) is estimated to post its quarterly earnings at $0.91 per share on revenue of $1.28 billion.
  • Brocade Communications Systems, Inc. (NASDAQ: BRCD) is projected to post its quarterly earnings at $0.22 per share on revenue of $640.09 million.
  • Palo Alto Networks Inc (NYSE: PANW) is estimated to post its quarterly earnings at $0.53 per share on revenue of


continue reading





The Mainstream Media Has Only Itself To Blame For The “Fake News” Epidemic

Courtesy of ZeroHedge. View original post here.

Submitted by Stephen Miller via HeatSt.com,

The mainstream media continues to freak out over the spread of “fake news” on Facebook and other social media platforms such as Twitter and reddit. Hillary Clinton’s late campaign thinks this is a problem.

The Democrat party seems to think people with Facebook accounts are to blame for Hillary’s decision to ignore crucial swing states in the final weeks of the campaign, that likely cost her the election.

But the media hasn’t bothered to ask why such sites gained traction. Our media has cultivated false news for years. Understandably, people stopped caring about the “journalistic ethics” the media claim to possess.

The CBS morning show, hosted by Charlie Rose, recently ran a segment on the rise of fake news, based on a story posted on BuzzFeed. The website claimed that Facebook users shared more “fake” news stories than “real” news stories by the end of the election.

Was the story true? Timothy Carney from the Washington Examiner found holes in Buzzfeed’s model which thus complicated the narrative BuzzFeed was trying to present. On examination, Buzzfeed had ignored real statistics to present their own version of a narrative, not the facts.

On the same CBS show, Charlie Rose interviewed former “fake news” pundit and left-wing icon Jon Stewart about the election. During his Daily Show years, Stewart styled himself as both a serious pundit and a comedian, allowing him to walk the line between fake news and satire.

The show’s set, and Stewart’s demeanor, mirrored that of a network news program. His cast did on-location interviews, which were often heavily edited to present their own liberal point of view. But long after Stewart’s show ended, he is still being propped up as an important voice in journalism.

Jon Stewart, “The Most Trusted Name in Fake News,” will quit The Daily Show this year: http://t.co/K3FqCFEdwd pic.twitter.com/5HOmV71Yxk

— CNN International (@cnni) February 11, 2015

Jon Stewart topped a 2009 TIME poll asking who was the most trusted newscaster in America http://t.co/6Vcooh7G3X pic.twitter.com/wDBZWuUUCP

— TIME (@TIME) August 7, 2015

Shortly before Stewart filmed his final Daily Show segment in August 2015, the Washington Post published a piece lamenting that “many millennials are about to lose their most-trusted news source.”

CNN’s Brian Stelter has made exposing fake


continue reading





Drugs Are Killing More Americans Than Road Crashes

Courtesy of ZeroHedge. View original post here.

So much for the so-called ‘war on drugs’… The United States has been gripped by a heroin and opiate epidemic with user numbers recently hitting a 20 year high.

In 2014, the number of U.S. heroin users passed the million mark with deaths from overdoses rising steeply. And as Statista’s Niall McCarthy writes, drugs are now killing substantially more Americans every year than car crashes.

In 2004, 30,711 deaths were drug related compared to 42,836 in


motor vehicle accidents. A decade later, drug-induced deaths reached


49,714 while road crash deaths fell to 32,675.

Infographic: Drugs Are Killing More Americans Than Road Crashes  | Statista

You will find more statistics at Statista

As well as the cheap suppy of heroin, legistlation aimed at eliminating prescription opioid abuse has actually added to the problem. It involved changing the texture of the pills to make them more difficult to crush and inject into the bloodstream. That move made people shift over to heroin in droves. New and deadlier drugs such as Fentanyl are also adding to the overdose epidemic. 50 times more potent than heroin, Fentanyl has created an overdose spike in several north-eastern states and has been named as the drug that killed pop singer Prince earlier this year.





“The Last Handshake” Caption Contest: The Final Photo Of Obama And Putin Together?

Courtesy of ZeroHedge. View original post here.

While China’s president Xi was busy dancing on the grave of TPP and rolling out its own regional free-trade alternative during the APEC summit in Peru, Obama was just as busy defending his vanishing legacy to an international audience for the last time. He was even busier projecting his denial before the entire world. As AFP reports, after the APEC summit closed on Sunday, Obama insisted that the 12-nation trans-Pacific deal, a key part of his now failed “pivot” to Asia, was far from dead and those involved still wanted to move forward with the United States.

Actually, no, it’s dead, but what is very much alive was Obama’s sudden realization that the policies he had been pushing for 8 years have led to a “globallized” world that has never been more splintered and where the wealth trickled-up, crushing the middle class just as the “fringe blogs” warned would happen:

The president also sought to answer rising concerns about globalization, saying that “historic gains in prosperity” had not been evenly distributed and there was a growing gap between rich and poor.

“That can reverberate through our politics,” he said. “That’s why I firmly believe one of our greatest challenges in the years ahead across our nations and within them will be to make sure that the benefits of the global economy are shared by more people.”

No Barack, it will not be your challenge. You are now out, leaving behind just a fake – and fading – facade of a recovery narrative built upon $15 trillion in global central bank liquidity, meant to prop up stock markets to all time highs even as a violent protest movement against your policies resulted in the biggest political shock of a generation… that and an all too real $20 trillion in government debt.

There is one way your departure will be missed, however: by exiting the global political arena, you will also deprive the world of what may have been the best photo ops ever: those between the departing US president, and the remaining Russian one.

Today, we witnessed one final such historic event, when in what is likely to be their last in-person meeting before Obama leaves office, the US president and his Russian counterpart


continue reading





Warren Buffett’s Meeting with University of Maryland MBA/MS Students – November 18, 2016

By Dr. David Kass. Originally published at ValueWalk.

(Notes primarily taken by Professor David Kass, Department of Finance, Robert H. Smith School of Business, University of Maryland.  Additional notes taken by Beija Fu, Yanting Ma, and Shiyue Wu were also included.)

Get The Full Warren Buffett Series in PDF

Get the entire 10-part series on Warren Buffett in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues.

We respect your email privacy

Warren Buffett

Warren Buffett (WB) (age 86) met with 20 MBA/MS or undergraduate students from each of eight universities/colleges, including the University of Maryland, on November 18, 2016.  (The other seven universities/colleges represented were, in alphabetical order, Boston University, Columbia University, Concordia (Montreal), Grinnell College, Marquette University, St. Louis University, and Yale University.)   Mr. Buffett responded to 20 student questions over 2 ½ hours.

Warren Buffett Berkshire Hathaway

Photo by thetaxhaven

Prior to responding to the questions, WB mentioned that his hearing is not as good as it used to be.  He said that recently he stood across the room from Charlie Munger (age 92) (CM) and said “Let’s buy General Motors at 33, do you agree?”  Since there was no response, he moved closer and repeated the same statement.  Again, no response.  Then he went very close to CM and repeated his statement.  CM replied “for the third time, yes!”

WB also invited all of the students to Berkshire’s next annual meeting in Omaha.  “Since Berkshire has invested in airline stocks”, the students “should fly first class to the annual meeting”.

Question 1:  What qualities do you look for in hiring people?

WB: Berkshire has only 25 people at headquarters, but 360,000 employees.  The managers of Berkshire’s 70 businesses choose their own people.  The qualities they look for are intelligence, energy, and integrity.  But the most important quality in a manager is having a passion for the business.  It is not IQ but passion for their businesses that make Berkshire’s 70 managers stand out. …
continue reading





“What Happened To Your ‘Love Trumps Hate’ Line? You’re All Damn Hypocrites!”

Courtesy of ZeroHedge. View original post here.

Fox’s Judge Jeanine Pirro tore into the cast of ‘Hamilton’ for their “inappropriate” behavior this weekend, slamming it as “out and out reverse racism that tee’d up hate for a man who has done nothing to deserve it.”

Pirro raged, Pence and President-elect Donald Trump won an election fair and square because “forgotten Americans, most of whom can’t afford tickets to your play, and may not have even heard of it, got up and voted” against the Democrats’ policies.

Pirro said Pence was trying to enjoy some time with his family after the grueling campaign and post-election transition work, but instead his presence was used “as a political bully pulpit.”

She noted that Hillary Clinton and Bernie Sanders attended the show in the past without issue.

“Last night violates everything you say you stand for. That big tent, inclusive broad-minded acceptance of everyone, even people who don’t look or act like you. What happened to your old ‘love trumps hate’ line? You’re all damn hypocrites!” she said.

Full rant below…

.@JudgeJeanine: “What happened to your old ‘love trumps hate’ line? You’re all damn hypocrites!” https://t.co/ho4V6NWSTo pic.twitter.com/BT8YC44Fjp

— Fox News (@FoxNews) November 20, 2016





 
 
 

Zero Hedge

Americans' Economic Hope Has Collapsed

Courtesy of ZeroHedge. View original post here.

Which came first, the confidence or the stock market rally?

One thing is for sure, the crash in stocks in December has crushed the hope of Americans that their economic future is going to be better under President Trump.

Overall confidence dipped to 58.1 - a 4-month low, but, U.S. consumers this month were the most downbeat on the economy since November 2016, a third straight drop after expectations reached a 16-year high just three months earlier, as the partial government shutdown wears on toward a fourth week.

...



more from Tyler

Kimble Charting Solutions

Triple Breakout Test In Play For S&P 500!

Courtesy of Chris Kimble.

Is the rally of late about to run out of steam or is a major breakout about to take place in the S&P 500? What happens at current prices should go a long way in determining this question.

This chart looks at the equal weight S&P 500 ETF (RSP) on a daily basis over the past 15-months.

The rally from the lows on Christmas Eve has RSP testing the top of a newly formed falling channel while testing the underneath side of the 2018 trading range and its falling 50-day moving average at (1).

At this time RPS is facing a triple resistance test. Wil...



more from Kimble C.S.

Phil's Favorites

Brexit deal flops, Theresa May survives -- so what happens now?

 

Brexit deal flops, Theresa May survives -- so what happens now?

Courtesy of Victoria Honeyman, University of Leeds

As the clock ticks down to March 29 2019, all of the political manoeuvring, negotiating, arguing and fighting is coming to a peak. In the two and a half years since the 2016 EU referendum, views on both sides have hardened and agreement still seems as far away as it was the day after the referendum.

With Theresa May’s withdrawal agreement disliked by all sides, and voted down by an unprecedented majority in the House of Commons, everyone is wondering what can and should be done next?

...



more from Ilene

Digital Currencies

Crypto-Bubble: Will Bitcoin Bottom In February Or Has It Already?

Courtesy of Michelle Jones via ValueWalk.com

The new year has been relatively good for the price of bitcoin after a spectacular collapse of the cryptocurrency bubble in 2018. It’s up notably since the middle of December and traded around the psychological level of $4,000... so is this a sign that the crypto market is about to recover?

Of course, it depends on who you ask, but one analyst discovered a pattern which might point to a bottom next month.

A year after the cryptocurrency bubble popped

CCN...



more from Bitcoin

ValueWalk

D.E. Shaw Investment Calls For Leadership Change At EQT

By ActivistInsight. Originally published at ValueWalk.

Elliott Management has offered to acquire QEP Resources for approximately $2.1 billion, contending the oil and gas explorer’s turnaround efforts have done little to lift the company’s share price. The company responded and said that a thorough review of the proposition is imperative in order to properly act in the best interests of shareholders, “taking into account the company’s other alternatives and current market conditions.” The news came only a month after Travelport Worldwide agreed to sell itself to Siris Capital Group and Elliott’s private equity arm Evergreen Coast Capital for $4.4 billion in cash and two months after Athenahealth was bought by Veritas and Evergreen for $5.7 bi...



more from ValueWalk

Insider Scoop

UBS Says Disney's Streaming Ambition Gives It A 'New Hope'

Courtesy of Benzinga.

Related DIS Despite Some Risks, Analysts Still Expecting Double Digit Growth From Communications Services In Q4 ...

http://www.insidercow.com/ more from Insider

Chart School

Weekly Market Recap Jan 13, 2019

Courtesy of Blain.

In last week’s recap we asked:  “Has the Fed solved all the market’s problems in 1 speech?”

Thus far the market says yes!  As Guns n Roses preached – all we need is a little “patience”.  Four up days followed by a nominal down day Friday had the market following it’s normal pattern the past nearly 30 years – jumping whenever the Federal Reserve hints (or essentially says outright) it is here for the markets.   And in case you missed it the prior Friday, Chairman Powell came back out Thursday to reiterate the news – so…so… so… patient!

Fed Chairman Jerome Powell reinforced that message Thursday during a discussion at the Economic Club of Washington where he said that the central bank will be “fle...



more from Chart School

Members' Corner

Why Trump Can't Learn

 

Bill Eddy (lawyer, therapist, author) predicted Trump's chaotic presidency based on his high-conflict personality, which was evident years ago. This post, written in 2017, references a prescient article Bill wrote before Trump even became president, 5 Reasons Trump Can’t Learn. ~ Ilene 

Why Trump Can’t Learn

Donald Trump by Gage Skidmore (...



more from Our Members

Biotech

Opening Pandora's Box: Gene editing and its consequences

Reminder: We are available to chat with Members, comments are found below each post.

 

Opening Pandora's Box: Gene editing and its consequences

Bacteriophage viruses infecting bacterial cells , Bacterial viruses. from www.shutterstock.com

Courtesy of John Bergeron, McGill University

Today, the scientific community is aghast at the prospect of gene editing to create “designer” humans. Gene editing may be of greater consequence than climate change, or even the consequences of unleashing the energy of the atom.

...

more from Biotech

Mapping The Market

Trump: "I Won't Be Here" When It Blows Up

By Jean-Luc

Maybe we should simply try him for treason right now:

Trump on Coming Debt Crisis: ‘I Won’t Be Here’ When It Blows Up

The president thinks the balancing of the nation’s books is going to, ultimately, be a future president’s problem.

By Asawin Suebsaeng and Lachlan Markay, Daily Beast

The friction came to a head in early 2017 when senior officials offered Trump charts and graphics laying out the numbers and showing a “hockey stick” spike in the nationa...



more from M.T.M.

OpTrader

Swing trading portfolio - week of September 11th, 2017

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Promotions

Free eBook - "My Top Strategies for 2017"

 

 

Here's a free ebook for you to check out! 

Phil has a chapter in a newly-released eBook that we think you’ll enjoy.

In My Top Strategies for 2017, Phil's chapter is Secret Santa’s Inflation Hedges for 2017.

This chapter isn’t about risk or leverage. Phil present a few smart, practical ideas you can use as a hedge against inflation as well as hedging strategies designed to assist you in staying ahead of the markets.

Some other great content in this free eBook includes:

 

·       How 2017 Will Affect Oil, the US Dollar and the European Union

...

more from Promotions





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>